CAPTAIN: Effects of age on response to triple therapy in patients with inadequately controlled asthma on ICS/LABA

被引：0
|
作者：
Boulet, Louis-Philippe [1 ]
Lee, Laurie [2 ]
Kerstjens, Huib [3 ,4 ]
Papi, Alberto [5 ]
Zarankaite, Agne [6 ]
Pavord, Ian D. [7 ]
Bailes, Zelie [6 ]
Brusselle, Guy [8 ]
Barnes, Neil [9 ,10 ]
Hanania, Nicola A. [11 ]
Pascoe, Steven [2 ]
Oppenheimer, John [12 ]
Pizzichini, Emilio [13 ,14 ,15 ,16 ]
Fowler, Andrew [6 ]
机构：
[1] Laval Univ, Quebec City, PQ, Canada
[2] GlaxoSmithKline, Collegeville, PA USA
[3] Univ Groningen, Groningen, Netherlands
[4] Univ Med Ctr Groningen, Groningen, Netherlands
[5] Univ Ferrara, Ferrara, Italy
[6] GlaxoSmithKline, Stockley Pk West, Uxbridge, Middx, England
[7] Univ Oxford, Oxford, England
[8] Ghent Univ Hosp, Ghent, Belgium
[9] GlaxoSmithKline, London, England
[10] London Sch Med & Dent, London, England
[11] Baylor Coll Med, Houston, TX 77030 USA
[12] Rutgers New Jersey Med Sch, Newark, NJ USA
[13] GlaxoSmithKline, Brentford, Middx, England
[14] Univ Fed Santa Catarina, Brentford, Middx, England
[15] GlaxoSmithKline, Florianopolis, SC, Brazil
[16] Univ Fed Santa Catarina, Florianopolis, SC, Brazil
来源：
EUROPEAN RESPIRATORY JOURNAL | 2020年 / 56卷
关键词：
Elderly; Treatments; Asthma;
D O I：
10.1183/13993003.congress-2020.2631
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2631
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils
    Brusselle, Guy
    Germinaro, Matthew
    Weiss, Sivan
    Zangrilli, James
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2017, 43 : 39 - 45
  • [32] Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma
    Dixon, Anne E.
    Dixon, Anne E.
    Castro, Mario
    Cohen, Rubin I.
    Gerald, Lynn B.
    Holbrook, Janet T.
    Irvin, Charles G.
    Mohapatra, Shyam
    Peters, Stephen P.
    Rayapudi, Sobharani
    Sugar, Elizabeth A.
    Wise, Robert A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (03) : 701 - +
  • [33] Reasons and outcomes for patients receiving ICS/LABA agents prior to, and one month after, emergency department presentations for acute asthma
    Villa-Roel, Cristina
    Borgundvaag, Bjug
    Majumdar, Sumit R.
    Emond, Marcel
    Campbell, Sam
    Sivilotti, Marco
    Abu-Laban, Riyad B.
    Stiell, Ian G.
    Aaron, Shawn D.
    Senthilselvan, Ambikaipakan
    Rowe, Brian H.
    JOURNAL OF ASTHMA, 2019, 56 (09) : 985 - 994
  • [34] A prospective study of switching asthma patients from a Fixed-Dose Combination (FDC) Inhaled Corticosteroid [ICS]/Long-Acting Beta Agonist [LABA] therapy delivered by Dry Powder Inhaler (DPI) to ICS/LABA delivered by pressurised Metered Dose Inhaler (pMDI)
    Al-Ahmad, Mona
    Webb, David
    RESPIRATORY MEDICINE, 2022, 194
  • [35] Comparing the efficacy and safety of formoterol/budesonide pMDI versus its mono-components and other LABA/ICS in patients with asthma
    Mukhopadhyay, Aniruddha
    Waked, Mirna
    Gogtay, Jaideep
    Gaur, Vaibhav
    RESPIRATORY MEDICINE, 2020, 170
  • [36] Rates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: An exploratory post-hoc analysis
    Dal Negro R.W.
    Borderias L.
    Zhang Q.
    Fan T.
    Sazonov V.
    Guilera M.
    Taylor S.D.
    BMC Pulmonary Medicine, 9 (1)
  • [37] Benralizumab: Effectiveness in Patients with Uncontrolled Severe Eosinophilic Asthma at 6 and 12 Months at a Third-Level Care Hospital. Capacity for ICS-LABA Therapy Reduction
    Gonzalez-Tuyub, Yair Humberto
    Gonzalez-Iniguez, Karla Daniela
    Lizarazo-Guiza, Paula Catalina
    Garcia-Garcia, Sergio Ricardo
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 1141 - 1149
  • [38] Reslizumab (RES) in patients (pts) with inadequately controlled asthma and elevated blood eosinophils (EOS): Analysis of two phase 3, placebo-controlled trials
    Virchow, Johann Christian
    Zangrilli, James
    Weiss, Sivan
    Korn, Stephanie
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [39] Efficacy and safety of once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol in Japanese patients with inadequately controlled asthma: the CAPTAIN study
    Nakamura, Yoichi
    Hozawa, Soichiro
    Sagara, Hironori
    Ohbayashi, Hiroyuki
    Lee, Laurie A.
    Crawford, Jodie
    Tamaoki, Jun
    Nishi, Takanobu
    Fowler, Andrew
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (09) : 1657 - 1665
  • [40] Effect of triple therapy in patients with asthma-COPD overlap
    Ishiura, Yoshihisa
    Fujimura, Masaki
    Ohkura, Noriyuki
    Hara, Johsuke
    Kasahara, Kazuo
    Ishii, Nobuyasu
    Tamaki, Takeshi
    Shimizu, Toshiki
    Nomura, Shosaku
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 57 (08) : 384 - 392
12345